Clinical Trial Update: Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) [Phase 1]

View source ↗

Summary

Phase 1 pharmacology study update of Brentuximab vedotin (SGN-35) has completed, according to clinical trials data. The study involves patients with Hodgkin lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Carcinoma
• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)

Snippet

Sponsor: Seagen Inc. | Conditions: Carcinomas, Disease, Hodgkin | Phase 1 | Status: COMPLETED